Tony Zhang

Company: Tyligand

Job title: Co-founder & Chief Executive Officer

Seminars:

Progress of Dual Action Tumor Immune Agonists to Produce a Durable Clinical Response for Treatment of Solid Tumors 3:00 pm

Harnessing the viability of tumor cells to produce cytokines that activate the innate immune system Modulating the potency and half-life of immune agonists for optimized antitumor efficacy and systematic tolerability Providing tumor neoatigens in situ to guide development of the emerging adaptive immune system Tipping the balance and break down barriers in the microenvironment of…Read more

day: Conference Day 2